Cryofocus Medtech (Shanghai) Co. Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
Profit Before Tax
-120.00
-116.00
-137.00
-152.00
-179.00
Adjustment
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-10.00
-20.00
-4.00
-9.00
12.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-90.00
-105.00
-112.00
-71.00
-36.00
Cash Flow from Investing Activities
-2.00
-16.00
-8.00
14.00
28.00
Cash Flow from Financing Activities
28.00
-15.00
196.00
238.00
0.00
Net Cash Inflow / Outflow
-62.00
-135.00
79.00
181.00
-8.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
1.00
3.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cryofocus Medtech (Shanghai) Co. Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-120.503890527465
234.179339294838
-354.00
-151.46%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-10.8921127217991
14.0320249696918
-24.00
-177.62%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-90.3863206303785
237.722582812143
-327.00
-138.02%
Cash Flow from Investing Activities
-2.03834082390825
-129.862910735963
127.00
98.43%
Cash Flow from Financing Activities
28.032607447951
-136.529803143523
164.00
120.53%
Net Cash Inflow / Outflow
-62.9001619990497
-28.6701310673436
-34.00
-119.39%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.49189200728604
0
1.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 14.63% vs 5.62% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-90.39
-105.88
14.63%






